Breaking news

Post of the Week

Dr. Reddy’s Laboratories Announces Launch of Oral Semaglutide Biosimilar ‘Obeda®’ (tablets) in India

Bengaluru – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), a global pharmaceutical company, today announced the launch of its oral semaglutide biosimilar, indicated for type 2 diabetes mellitus. Dr. Reddy’s oral semaglutide is available in tablet form under the brand […]

View all

Travel2Films

Share

Follow us @ Facebook

Follow Us @ Twitter

Bengaluru
78°
light rain
humidity: 76%
wind: 23mph W
H 92 • L 73
93°
Fri
85°
Sat
85°
Sun
84°
Mon
85°
Tue
Weather from OpenWeatherMap